吉西他滨联合替吉奥治疗晚期胰腺癌疗效观察(2)
参考文献：
[1]夏金堂，徐波.胰腺癌非手术治疗的现状和展望[J].实用医学杂志，2010，26(10)：1685-1687.
[2]Murakami Y，Uemura K，Sudo T，et al.Adjuvant gemcitabine plus S-1 chemotberapy after surgical resection for pancreatic adenocarcinoma[J].Am J Surg，2008，195：757-762.
[3]Murakami Y，Uemura K，Sudo T，et al.Impact gemcitabine plus S-1 chemotberapy after surgical resection for adenocarcinoma of the luxly or tail of the pancreas[J].J Gas-trointest surg，2009，13：85-92.
[4]郭春光，赵平.胰腺癌分子靶向治疗进展[J].癌症进展，2008，6(1)：25.
[5]Tanaka F，Fukuse T，Wada H，et al.The history，mechanism and clinical use of oral 5-fluorouracil derivative chemotherapeutic agants[J].Curr Pharm Biotechnol，2000，1：137-164.
[6]Shirasaka T，Shimamato Y，Ohshimo H，et al.Development of a novel form of an oral 5-fluorouracil derivative (S-1) directed to the potentiation of the tumor selective cytotoxicity of 5-fluorouracil by two biochemical modulators[J].Antiancer Drugs，1996，7：548-557.
[7]Nakamura K，Yamaguchi T，Ishihara T，et al，Phase II trial of oral S-l combined with gemcitabine in metastatic pancreatic pancreatic cancer[J].Br J Cancer，2006，94(11)：1575-1579.
編辑/周芸霏, 百拇医药(张颖 邵玲玲)
[1]夏金堂，徐波.胰腺癌非手术治疗的现状和展望[J].实用医学杂志，2010，26(10)：1685-1687.
[2]Murakami Y，Uemura K，Sudo T，et al.Adjuvant gemcitabine plus S-1 chemotberapy after surgical resection for pancreatic adenocarcinoma[J].Am J Surg，2008，195：757-762.
[3]Murakami Y，Uemura K，Sudo T，et al.Impact gemcitabine plus S-1 chemotberapy after surgical resection for adenocarcinoma of the luxly or tail of the pancreas[J].J Gas-trointest surg，2009，13：85-92.
[4]郭春光，赵平.胰腺癌分子靶向治疗进展[J].癌症进展，2008，6(1)：25.
[5]Tanaka F，Fukuse T，Wada H，et al.The history，mechanism and clinical use of oral 5-fluorouracil derivative chemotherapeutic agants[J].Curr Pharm Biotechnol，2000，1：137-164.
[6]Shirasaka T，Shimamato Y，Ohshimo H，et al.Development of a novel form of an oral 5-fluorouracil derivative (S-1) directed to the potentiation of the tumor selective cytotoxicity of 5-fluorouracil by two biochemical modulators[J].Antiancer Drugs，1996，7：548-557.
[7]Nakamura K，Yamaguchi T，Ishihara T，et al，Phase II trial of oral S-l combined with gemcitabine in metastatic pancreatic pancreatic cancer[J].Br J Cancer，2006，94(11)：1575-1579.
編辑/周芸霏, 百拇医药(张颖 邵玲玲)